Real Money

WAYNE, Pa., Nov. 16, 2016 /PRNewswire/ -- Ryan & Maniskas, LLP announces that a class action lawsuit has been filed in United States District Court for the Eastern District of Michigan on behalf of all persons or entities that purchased Diplomat Pharmacy, Inc. (NYSE: DPLO) ("Diplomat Pharmacy" or the "Company") common shares between October 9, 2014 and November 2, 2016, inclusive (the "Class Period").

Diplomat Pharmacy shareholders may, no later than January 9, 2017, move the Court for appointment as a lead plaintiff of the Class. If you purchased shares of Diplomat Pharmacy and would like to learn more about these claims or if you wish to discuss these matters and have any questions concerning this announcement or your rights, contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or to sign up online, visit: www.rmclasslaw.com/cases/dplo.

Diplomat Pharmacy operates one of the largest independent specialty pharmacy networks in the United States.

The complaint alleges that defendants made materially false and misleading statements regarding the Company's business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate internal controls over its financial reporting; (2) as a result the Company could not adequately calculate DIR fees; (3) the Company's hepatitis C segment was not performing as previously disclosed to investors; (4) and therefore, the Company had overstated its full-year 2016 guidance; and (5) that, as a result of the foregoing, defendants' statements about the Company's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.